Natalizumab monoclonal antibody drug. Targets integrin a4 and is indicated for use in the treatment of multiple sclerosis and. #186815126
Description
Natalizumab monoclonal antibody drug. Targets integrin a4 and is indicated for use in the treatment of multiple sclerosis and Crohn`s disease. Generic name and stylized antibody representation